VC Firm Dimension Raises $500 Million to Bet on AI and Medicine

Dimension Capital, a venture firm targeting life sciences and technology startups, has raised $500 million just two years after debuting its first fund.

The New York-based firm aims to tap into trends such as the growth of artificial intelligence and the rise of new ways to develop medicine — particularly the use of technology in the search for new drugs.

Nan Li, from left, Zavain Dar and Adam Goulburn.

Source: Dimension Capital

Recent advances represent “a generational shift in how life sciences are practiced,” said Dimension founder and managing partner Nan Li. Periods when an industry undergoes intense and rapid change are “typically where you see really interesting companies formed,” he said. ...